Implementation of Fluid Strategies Using Real-time Bioelectrical Analyzer in Surgical Intensive Care Unit (SICU)

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Fluid OverloadFluid Loss
Interventions
DRUG

Active fluid management with BIA monitoring

The participants in active fluid management with BIA monitoring arm received fluid supplementation targeting specific range of ECW ratio by BIA (0.390-0.406). If a patient with dehydrated status indicated by the ECW ratio was less than 0.390, a bolus infusion was performed using 250ml of crystalloid fluid (PlasmaLyte). If a patient with overhydrated status indicated by the ECW ratio was more than 0.406, 10mg of furosemide was administered. Changes in the ECW ratio were measured at one hour after initial intervention for fluid adjustment, and these processes continued until the ECW ratio was within the normal range (0.390-0.406).

DRUG

Conventional fluid management without BIA monitoring

The participants in conventional fluid management without BIA monitoring arm underwent conventional fluid management without specific targets of ECW ratio by BIA.

Trial Locations (1)

137-701

Division of Trauma and Surgical Critical Care, Department of Surgery, Seoul St. Mary's Hospital, Seoul

All Listed Sponsors
lead

Seoul St. Mary's Hospital

OTHER

NCT06097923 - Implementation of Fluid Strategies Using Real-time Bioelectrical Analyzer in Surgical Intensive Care Unit (SICU) | Biotech Hunter | Biotech Hunter